CTUM will spike, regardless of any, or any types of promotion. What I refer to is simply bringing attention to LTC in ways that, to date, Don has not wanted to afford for one reason or another.
For instance, LTC as a focused subject in the Journal of American Medicine Association.
FDA approval opens the door to public awareness which was not previously preferred and or desired. Don has not wanted to bring too much attention to LTC for several reasons. One reason being that other (competitor) industries may not take too kindly to 'the new kid on the block'. Another reason could easily be understood not wanting to put the carriage before the horse.
I may be wrong, but I believe once approved, the underwriters of LTC's IPO will have full license to promote the IPO in whatever appropriate manners they may deem beneficial, and may already be budgeted to accommodate this.
While spikes are inevitable, growing interest will be an ongoing thing for oh, the next 10-20 years? (lol)
CTUM could quite easily be a retirement stock, if enough of it were owned prior to approval, and enough of it were kept for atleast 5 years.
Daytraders (and their 10 minute minds) are not able to think that far into the future, but there are many who are. Also, the further CTUM and LTC get's from the pennies, the less daytraders/flippers will be playing it.
Without question, CTUM is the bluechip of all pennystocks, perhaps of all time.